Xeroderma pigmentosum: genes and variants
Explore variant evidence for Xeroderma pigmentosum across 7 analyzed proteins (ERCC2, ERCC5, XPA, ERCC4, XPC and 2 more). Linked ClinVar records include 34 pathogenic or likely pathogenic variants, 574 variants of uncertain significance and 75 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Xeroderma pigmentosum
ERCC2: General transcription and DNA repair factor IIH helicase subunit XPD
Its XPD helicase activity unwinds damaged DNA during nucleotide-excision repair and also supports transcription initiation within TFIIH. Biallelic pathogenic variants cause xeroderma pigmentosum, trichothiodystrophy, or combined DNA-repair syndromes depending on the functional defect.
15 ClinVar pathogenic / likely pathogenic and 70 uncertain variants in ERCC2 have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
ERCC5: DNA excision repair protein ERCC-5
It makes one of the two strand incisions required to remove bulky DNA lesions during nucleotide-excision repair and also supports repair-associated transcriptional responses. Biallelic pathogenic variants can cause xeroderma pigmentosum group G, Cockayne syndrome, or combined phenotypes.
8 ClinVar pathogenic / likely pathogenic and 56 uncertain variants in ERCC5 have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
XPA: DNA repair protein complementing XP-A cells
It verifies bulky DNA lesions and organizes the nucleotide-excision-repair machinery around damaged sites. Biallelic loss-of-function variants cause xeroderma pigmentosum group A with extreme ultraviolet sensitivity, early skin cancers, and often progressive neurologic disease.
6 ClinVar pathogenic / likely pathogenic and 20 uncertain variants in XPA have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
ERCC4: DNA repair endonuclease XPF
Together with ERCC1, it makes structure-specific DNA incisions required for nucleotide-excision repair and interstrand-crosslink repair. Biallelic pathogenic variants can cause xeroderma pigmentosum, Fanconi anemia, or severe progeroid DNA-repair disease.
2 ClinVar pathogenic / likely pathogenic and 378 uncertain variants in ERCC4 have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
XPC: DNA repair protein complementing XP-C cells
It detects helix-distorting lesions throughout the genome and initiates global-genome nucleotide-excision repair. Biallelic loss-of-function variants cause xeroderma pigmentosum group C with severe ultraviolet sensitivity and greatly increased skin-cancer risk.
2 ClinVar pathogenic / likely pathogenic and 78 uncertain variants in XPC have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
ERCC3: General transcription and DNA repair factor IIH helicase/translocase subunit XPB
The XPB helicase/translocase subunit of TFIIH, used in transcription initiation and nucleotide-excision repair. Variants can cause xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy.
1 ClinVar pathogenic / likely pathogenic and 34 uncertain variants in ERCC3 have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
POLH: DNA polymerase eta
DNA polymerase eta bypasses UV-induced DNA lesions during translesion synthesis. Deficiency causes the variant form of xeroderma pigmentosum.
0 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in POLH have source records linked to Xeroderma pigmentosum. Association strength is not clinical gene validity.
Where Xeroderma pigmentosum variants cluster
- ERCC5 I-domain (positions 786–881): 4 of 8 ClinVar pathogenic / likely pathogenic variants, 6.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Xeroderma pigmentosum
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ERCC2 R658C | 658 | Pathogenic / likely pathogenic (★★) | |
| ERCC2 G47R | 47 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| ERCC2 S541R | 541 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| XPA C126W | 126 | Zinc finger | Pathogenic / likely pathogenic (★★) |
| ERCC2 R616P | 616 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 R616W | 616 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 R511Q | 511 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC5 G805R | 805 | I-domain | Pathogenic / likely pathogenic (★★) |
| XPA C108F | 108 | Zinc finger | Pathogenic / likely pathogenic (★★) |
| XPC Y585C | 585 | Interaction with RAD23B | Pathogenic / likely pathogenic (★★) |
| ERCC2 R112H | 112 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| ERCC2 C259Y | 259 | Helicase ATP-binding | Pathogenic / likely pathogenic (★★) |
| ERCC2 R601L | 601 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★★) |
| ERCC2 T709P | 709 | Pathogenic / likely pathogenic (★★) | |
| ERCC4 C236R | 236 | Leucine-zipper 1 | Pathogenic / likely pathogenic (★★) |
| ERCC4 R689S | 689 | ERCC4 | Pathogenic / likely pathogenic (★★) |
| ERCC5 A792V | 792 | I-domain | Pathogenic / likely pathogenic (★★) |
| XPA Q185H | 185 | Pathogenic / likely pathogenic (★★) | |
| XPC M1R | 1 | Pathogenic / likely pathogenic (★★) | |
| ERCC5 A818V | 818 | I-domain | Pathogenic / likely pathogenic (★★) |
| XPA G95R | 95 | Interaction with CEP164 and required for UV resi | Pathogenic / likely pathogenic (★★) |
| ERCC2 R658G | 658 | Pathogenic / likely pathogenic (★) | |
| XPA R130K | 130 | Pathogenic / likely pathogenic (★) | |
| ERCC2 C663R | 663 | Pathogenic / likely pathogenic (★) | |
| ERCC3 F99S | 99 | Pathogenic / likely pathogenic (★) | |
| ERCC5 L778P | 778 | Spacer region | Pathogenic / likely pathogenic (★) |
| ERCC2 L461V | 461 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic (★) |
| XPA M1T | 1 | Pathogenic / likely pathogenic (★) | |
| ERCC2 A717G | 717 | Pathogenic / likely pathogenic (★) | |
| ERCC2 L485P | 485 | Mediates interaction with MMS19 | Pathogenic / likely pathogenic |
| ERCC5 A28D | 28 | N-domain | Pathogenic / likely pathogenic |
| ERCC5 P72H | 72 | N-domain | Pathogenic / likely pathogenic |
| ERCC5 L858P | 858 | DNA-binding | Pathogenic / likely pathogenic |
| ERCC5 W968C | 968 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Xeroderma pigmentosum
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| ERCC2 R616Q | 616 | Mediates interaction with MMS19 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R616P at the same position is pathogenic; REVEL 0.911 |
Which prediction tools work for Xeroderma pigmentosum
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- CADD: 93 out of 100
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 92 out of 100
- phyloP: 88 out of 100
- SpliceAI: 68 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 44 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Cerebrooculofacioskeletal syndrome also has ClinVar records linked to ERCC2 variants; they fall partly in the same places as the Xeroderma pigmentosum variants (15 pathogenic / likely pathogenic).
Diseases related to Xeroderma pigmentosum
- Ovarian cancer, also linked to ERCC2, ERCC3, ERCC4, ERCC5 and 1 more
- Cerebrooculofacioskeletal syndrome, also linked to ERCC2 and ERCC5
- Trichothiodystrophy 1, photosensitive, also linked to ERCC2 and ERCC3
- Fanconi anemia complementation, also linked to ERCC4
- Acute myeloid leukemia, also linked to ERCC4
- Fanconi anemia, also linked to ERCC4
- Urinary bladder cancer, also linked to ERCC2
- Basal cell carcinoma, also linked to XPA
- Cockayne syndrome, also linked to ERCC4
- Trichothiodystrophy 2, photosensitive, also linked to ERCC3
- Xeroderma pigmentosum variant type, also linked to POLH
- XFE progeroid syndrome, also linked to ERCC4
Frequently asked questions
Which genes have records linked to Xeroderma pigmentosum?
This view contains 7 analyzed proteins: ERCC2, ERCC5, XPA, ERCC4, XPC and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 34 pathogenic or likely pathogenic variants, 574 variants of uncertain significance and 75 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 884 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center